« Back
Home /
Adebrelimab (Anti-B7-H1 / PD-L1 / CD274)

Adebrelimab (Anti-B7-H1 / PD-L1 / CD274)

Item no.	A2775-25mg
Manufacturer	Selleckchem
CASRN	2247114-85-6
Amount	1 mg x 25
Quantity options	1 mg 1 mg x 25 1 mg x 5
Specific against	other
Alias	SHR-1316
Available
Storage Conditions	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Information	Adebrelimab (Anti-B7-H1 / PD-L1 / CD274) is a humanized immunoglobulin G4 (IgG4) monoclonal antibody directed against the immunosuppressive ligand programmed cell death-1 ligand 1 (PD-L1, cluster of differentiation 274, CD274) with promising antitumor activity in solid tumors including extensive-stage small-cell lung cancer (SCLC). MW: 145.8 kD.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

A2775-25mg-safety-datasheet.pdf